Drug intelligence / Profile preview

qigui fushe jiaonang

Development stage: Unknown
Lead developer: Zhejiang Xinmingzhu Pharmaceutical
Administration: Oral

Overview

Qi Gui Fu She Capsules (芪归蝮蛇胶囊) is a traditional Chinese medicine (TCM) product developed and manufactured by Zhejiang Xinmingzhu Pharmaceutical. It is an approved pharmaceutical in China, typically indicated for the treatment of rheumatoid arthritis, osteoarthritis, and bone hyperplasia (hyperosteogeny). The formulation combines herbal ingredients such as *Astragalus membranaceus* (Huangqi) and *Angelica sinensis* (Danggui) with animal-derived components from *Agkistrodon* (Fushe/Viper). Pharmacologically, it is intended to nourish Qi and blood, dispel wind-dampness, and unblock the meridians to alleviate joint pain, swelling, and stiffness associated with chronic rheumatic conditions.

Brand names: Qi Gui Fu She Capsules
Other names: 芪归蝮蛇胶囊

Beyond the preview

Go deeper on qigui fushe jiaonang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on qigui fushe jiaonang.

Explore the full profile